David Vicente-Zurdo is currently a Doctor Collaborating Professor in the area of Analytical Chemistry at the Center for Metabolomics and Bioanalysis (CEMBIO), located in the Faculty of Pharmacy of the San Pablo-CEU University, CEU University. He graduated from the Department of Analytical Chemistry, Nutrition, and Bromatology of the University of Salamanca. In 2017, he obtained a Master’s degree in Chemical Science and Technology (Instrumentation and Analysis Mode) from the Complutense University of Madrid, where he continued his doctoral studies. In 2023 he obtained the title of Doctor (excellent Cum Laude, international mention) from the UCM. Currently, his research work is focused on evaluating various species of selenium, organic molecules, and extracts of the food industry as possible drugs in the treatment of Alzheimer’s, using a linear ion trap with electrospray ionization coupled to liquid chromatography (HPLC-ESI-IT). In addition, he has carried out incubations of the beta-amyloid protein and done inhibition studies on its aggregation induced by metals involved in neurodegenerative diseases.
David Vicente-Zurdo is currently a Doctor Collaborating Professor in the area of Analytical Chemistry at the Center for Metabolomics and Bioanalysis (CEMBIO), located in the Faculty of Pharmacy of the San Pablo-CEU University, CEU University. He graduated from the Department of Analytical Chemistry, Nutrition, and Bromatology of the University of Salamanca. In 2017, he obtained a Master’s degree in Chemical Science and Technology (Instrumentation and Analysis Mode) from the Complutense University of Madrid, where he continued his doctoral studies. In 2023 he obtained the title of Doctor (excellent Cum Laude, international mention) from the UCM. Currently, his research work is focused on evaluating various species of selenium, organic molecules, and extracts of the food industry as possible drugs in the treatment of Alzheimer’s, using a linear ion trap with electrospray ionization coupled to liquid chromatography (HPLC-ESI-IT). In addition, he has carried out incubations of the beta-amyloid protein and done inhibition studies on its aggregation induced by metals involved in neurodegenerative diseases.